These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2010560)

  • 1. Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging study.
    Carr AA; Bottini PB; Prisant LM; Fisher LD; Devane JG; O'Brien DE; Rhoades RB
    J Clin Pharmacol; 1991 Feb; 31(2):144-50. PubMed ID: 2010560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning.
    Smith DH; Neutel JM; Weber MA
    Am J Hypertens; 2001 Jan; 14(1):14-9. PubMed ID: 11206672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil 240 SR versus verapamil 120 SR in arterial hypertension. A randomized double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
    Corea L; Bentivoglio M; Berioli S; Bianchini C; Savino K; Sardina M
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1501-7. PubMed ID: 2081142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of dose to the antihypertensive response of verapamil-sustained release in patients with mild to moderate essential hypertension. The Verapamil-SR Study Group.
    McMahon FG; Reder RF
    J Clin Pharmacol; 1989 Nov; 29(11):1003-7. PubMed ID: 2689469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sustained-release formulations of nicardipine and verapamil for mild to moderate systemic hypertension.
    Gradman AH; Frishman WH; Kaihlanen PM; Wong SC; Friday KJ
    Am J Cardiol; 1992 Dec; 70(20):1571-5. PubMed ID: 1466325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice-daily administration of oral verapamil in the treatment of essential hypertension.
    Frishman W; Charlap S; Kimmel B; Saltzberg S; Stroh J; Weinberg P; Monuszko E; Wiezner J; Dorsa F; Pollack S
    Arch Intern Med; 1986 Mar; 146(3):561-5. PubMed ID: 3954530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning.
    Neutel JM; Alderman M; Anders RJ; Weber MA
    Am Heart J; 1996 Dec; 132(6):1202-6. PubMed ID: 8969572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.
    Nissinen A; Koistinen A; Tuomilehto J; Sundberg S; Gordin A
    Eur J Clin Pharmacol; 1986; 31(3):255-9. PubMed ID: 3539623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
    Graney WF
    Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S89-93. PubMed ID: 2467138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
    de Leeuw PW; Notter T; Zilles P
    J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.
    Caruana M; Heber M; Brigden G; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):549-53. PubMed ID: 3653223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.